Xconomy

APRIL 25, 2018

Biogen (NASDAQ: BIIB ) was the first to bring an SMA drug to market, the RNA drug nusinersen (Spinraza), a chronic treatment that has shown an ability to help people with multiple forms of the progressive disease. Now two cutting-edge therapies look headed for a commercial battle, with each data and revenue update a key moment in the race.

Sales 74

Sales Help Marketing San Diego 74

Xconomy

APRIL 25, 2017

In the fiscal year that ended last June, the San Diego maker of respiratory machines for maintaining continuous positive airway pressure (CPAP) generated over $1.8 billion in global sales.

San Diego 74

San Diego Sales Technology Marketing 74

Xconomy

JUNE 16, 2016

What does it take to build a startup in today’s market? Put a half-dozen entry-level tech entrepreneurs together anywhere outside of the Bay Area, and it won’t take long before they start listing the local market deficiencies. In San Diego, the complaints often focus on the relative scarcity of venture capital and hometown VC firms.

Venture Capital 49

Venture Capital San Diego Truecar Web 49

Xconomy

MAY 10, 2019

The market for drugs for rare or “orphan” diseases continues to grow. An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. Soon there could be three.

Pricing 97

Pricing Sales Competition Report 97

Xconomy

AUGUST 26, 2019

Four years after approval the two PCSK9 blockers on the market have yet to crack $1 billion in annual sales, combined, thanks to a gloves-off effort by insurers to beat back their use. Far from it. One of the two drugs might even be on life support. Now a third PCSK9 inhibitor is in the ring.

Study 102

Study Conference Sales Marketing 102

Xconomy

NOVEMBER 30, 2016

San Diego-based AttackIQ, a cybersecurity startup providing a Web-based platform for assessing network defenses, has finally closed its Series A round of founding, after raising a total of $8.8 Institutional investors included San Francisco-based Index Ventures , Qualcomm Ventures , and Telstra Ventures.

Tool 40

Tool San Diego Web Platform 40

Xconomy

MARCH 12, 2018

The news follows years of ups and downs for Orexigen, which piled up debt as it struggled to successfully market its obesity drug, known as Contrave. Orexigen Therapeutics has filed for bankruptcy to sell its weight loss pill to the highest bidder.

Sales 59

Sales News Help Marketing 59

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. billion , according to ArcView Market Research. The ArcView Group is a partner in CanopyBoulder). percent.

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

AUGUST 1, 2016

PacketSled, a cybersecurity startup based in suburban San Diego, has raised $5 million in a Series A funding round led by Keshif Ventures, a local angel investment fund that has put money into dozens of tech startups in the San Diego area. Two other small funds, Blu Ventures and JHS Ventures joined in the round.

San Diego 40

San Diego Conference Funding Networking 40

Xconomy

JULY 29, 2019

With ambitious sales goals and its stock trading at an all-time high this year, cancer diagnostics firm Exact Sciences decided to go shopping. ” In pre-market. . ” In pre-market. The result is a deal announced Monday to acquire Genomic Health for $2.8 Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Conference 100

Conference Sales Invest Marketing 100

Xconomy

AUGUST 22, 2016

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego.

Develop 40

Develop Development San Diego Startup 40

Xconomy

MAY 4, 2017

San Antonio — Cytori Therapeutics is in the process of restarting a San Antonio manufacturing facility it gained in February when it acquired Azaya Therapeutics, the maker of nanoparticle-encapsulated generic drugs. The San Diego-based company now plans to find a European distributor for a drug that facility makes.

San Diego 40

San Diego Sites Marketing Company 40

Xconomy

AUGUST 8, 2016

It’s been less than a year since Needham, MA-based PTC (NASDAQ: PTC ) shelled out $65 million to acquire Vuforia, the augmented reality technology created by San Diego-based Qualcomm (NASDAQ: QCOM ). Vuforia’s headquarters has remained in San Diego, and Vuforia continues to operate four offices in Europe and Israel, Wright said.

San Diego 40

San Diego Mobile Examples .Net 40

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service. Including the latest round, Petnet has raised a total of $21.5

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

DECEMBER 7, 2018

Aha makes a program that helps project managers develop new product roadmaps, which are used by others in the customer’s business, from sales. Founded in 2013 by de Haaff and Chris Waters in the Bay Area, the company announced in July it had surpassed $40 million in annual recurring revenue from the subscribers to its software-as-a-service.

Sales 100

Sales Software Services Startup 100

Xconomy

MAY 8, 2017

Beginning with eHeaven, an e-commerce website that he founded in 2000 as a student at San Diego’s Point Loma Nazarene University, Carder has ridden a series of enormous waves as consumers moved online to shop, search for home loans, and find businesses in their neighborhoods.

Commerce 59

Commerce Sales Startup Web 2.0 59

Xconomy

JULY 30, 2019

About this time last year, DNA sequencing giant Illumina upped its financial projections, estimating its sales would grow 20 percent year-over-year. On Monday, Illumina (NASDAQ: ILMN ) informed the markets that it had overshot the mark with its 2019 estimates. It exceeded that goal, with revenue rising 21 percent to $3.33

Study 59

Study News Demand Tool 59

Xconomy

MAY 9, 2017

There’s a lot of additional engineering and software development that needs to be done, and Edico also plans to expand its sales and marketing team, CEO Pieter. The new cash, which brings Edico’s total funding to $32 million, will be used to fuel expansion and further development of Edico’s Dragen technology.

Web 77

Web Services Software Development Sales 77

Xconomy

DECEMBER 27, 2017

elections, democracy, free speech, fairness in hiring, sexual harassment, privacy, data security, and the future job market for humans in the age of robots and artificial intelligence. We’ve just passed a year full of news about the role of technology companies in U.S.

Artificial Inteligence 58

Artificial Inteligence News Sales Marketing 58

Xconomy

OCTOBER 16, 2016

After raising $30 million, San Diego-based Certona said it is moving to accelerate its product development, expand its sales and marketing team, and improve its client services as an e-commerce technology vendor. When you get all that data and analyze it, you get interesting insights,” Sheik said.

Artificial Inteligence 40

Artificial Inteligence Commerce San Diego Web 40

Xconomy

APRIL 2, 2018

says Drew Giovannoli, product marketing manager at Bazaarvoice, an Austin, TX-based maker of e-commerce software. Personalized service once meant a salesperson remembered customers’ favorite colors or would call to let them know about upcoming sales. But dialing shoppers one at a time is.

Commerce 59

Commerce Guide Web Mobile 59

Xconomy

MARCH 1, 2019

biopharmaceutical industry is dealing with unprecedented threats on several fronts: public backlash against high drug prices, slowing sales, and the possibility of more government regulation. After years of boom times, the U.S.

Report 83

Report Pricing Sales San Diego 83

Xconomy

MARCH 9, 2018

Two came to market in 2015, chalking up relatively meager sales for their owners. In the debate over high drug prices, arguably no class of drug has been punished more by insurers than the new cholesterol fighters called PCSK9 inhibitors. Meanwhile, a rival drug company thinks it.

Pricing 56

Pricing Class Sales Marketing 56

Xconomy

MAY 1, 2018

Sales of weight loss drugs have been light, and the Vivus drug Qsymia is no exception. The treatment is currently marketed by Janssen Pharmaceuticals. Facing declining revenue as well as a looming mountain of debt, Vivus has been casting about for a new strategy. It looks like it’s found one. and Canada. and Canada.

Sales 49

Sales Marketing San Diego Company 49

Xconomy

MARCH 17, 2017

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more important—drive insurers to loosen their restrictions. political issue, and pricey new cholesterol drugs have been a key battleground.

Study 87

Study Pricing Sales Journal 87

Xconomy

AUGUST 8, 2016

The remaining $444 million depends on meeting future development, regulatory, and sales-based milestones, with additional future revenue tied to royalty payments in selected territories.

Study 40

Study San Diego News Design 40

Xconomy

OCTOBER 14, 2016

That means in three months, Bristol has lost a third of its value, equivalent to about $40 billion in market capitalization. —Shares of San Diego-based Illumina (NASDAQ: ILMN ) fell more than 32 percent after the next-gen sequencing giant slashed its revenue projections once again. Today, shares are worth just over $50.

News 40

News San Diego Incubator Research 40

Xconomy

JULY 26, 2016

In contrast to some alternative lenders, the San Diego firm said it is growing fast and is consistently profitable. LendingClub stumbled earlier this year, however, when an internal investigation found improprieties in the sale of $22 million in loans.

Software Review 40

Software Review San Diego Funding Customer 40

Xconomy

NOVEMBER 10, 2016

People will also be able to purchase insurance across state lines, even though the states will be in charge of regulating their markets. A scholar at the American Enterprise Institute wrote earlier this year that “one should not expect interstate sales to significantly reduce the cost of health insurance.”

Pricing 106

Pricing Innocal Sites Design 106

Xconomy

JULY 1, 2016

Traded on the London Stock Exchange, its shares held steady while the market went haywire, then climbed all week through Thursday’s close. Shares were down nearly 8 percent in aftermarket trading… Boehringer Ingelheim said it would lay off 724 jobs , mainly in sales, across the U.S.,

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JULY 21, 2016

It’s currently Biogen’s top-selling product, generating close to $2 billion in sales during the first half of 2016. In May, Biogen even announced plans to spin off its hemophilia business —which includes two marketed drugs for the blood disease—into a new company. George joined Biogen at a very challenging time.

San Diego 40

San Diego Conference Pricing Acquisition 40

Xconomy

AUGUST 5, 2016

Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. As a result, Biogen will buy the rights to nusinersen and prepare to ask regulators for marketing approval. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

OCTOBER 18, 2016

Sales of both drugs, ivacaftor (Kalydeco) and the combo pill ivacaftor-lumacaftor (Orkambi), reached almost $1 billion in 2015 and are growing. Telaprevir sales rocketed to nearly $1 billion in the first six months, at the time the fastest drug launch ever. In its early days, Vertex helped bring two HIV drugs to market.

Startup 40

Startup Research Sales Organization 40

Xconomy

JULY 29, 2016

But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. The changing dynamic of the hepatitis C market will be acknowledged in the presidential campaign: yes or no.

Startup 40

Startup Study News Report 40

Xconomy

JULY 15, 2016

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —San Antonio, TX-based StemBioSys inked its second distribution deal in as many months, announcing plans to bring its stem cell production products to South Korea.

News 40

News Technical Review San Diego Startup 40

Xconomy

JULY 21, 2016

Blakely said he also intends to add sales and marketing resources to take advantage of increasing demand from businesses for Zingle’s messaging technology. Happy #TBT from our fearless Founder & CEO @fordblakely ! Hate2Wait #H8toW8 pic.twitter.com/KcMuKvoqRZ. Zingle (@ZingleMe) July 14, 2016.

Technology 40

Technology Santa Barbara Venture Capital Venice 40

Xconomy

JUNE 30, 2016

Several drugs to block bad integrin behavior and treat a range of maladies have come to market. These drugs, like sibrafiban, lotrafiban, and orbofiban , were found to actually increase the risk of strokes and heart attacks rather than prevent them, and they never came to market. They actually killed people.”. “So

Startup 40

Startup Invest Journal Research 40